Relationship between body mass index, waist circumference and waist to hip ratio and the steroid hormone receptor status in breast carcinoma of pre- and postmenopausal women

Breast

Volumn 18, Issue 1, 2009, Pages 8-12

  Pinheiro, Rosilene Lima ^a,b   Sarian, Luis Otavio ^b   Pinto Neto, Aarão Mendes ^b   Morais, Sirlei ^b   Costa Paiva, Lucia ^b  

^a INSTITUTO NACIONAL DE CÂNCER   (Brazil)

^b UNIVERSITY OF CAMPINAS   (Brazil)

Author keywords

Body mass index; Breast cancer; Central obesity; Menopause; Steroid receptors

Indexed keywords

ESTROGEN RECEPTOR; ORAL CONTRACEPTIVE AGENT; PROGESTERONE RECEPTOR;

ADULT; ARTICLE; BODY HEIGHT; BODY MASS; BODY WEIGHT; BREAST CANCER; BREAST CARCINOMA; CANCER RISK; CANCER STAGING; CONTROLLED STUDY; ESTROGEN SYNTHESIS; FEMALE; HORMONAL THERAPY; HUMAN; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; OBESITY; POSTMENOPAUSE; PREDICTION; PREMENOPAUSE; PRIORITY JOURNAL; WAIST CIRCUMFERENCE; WAIST HIP RATIO;

EID: 59849126989     PISSN: 09609776     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.breast.2008.09.001     Document Type: Article

References (34)

1. Greenwald P. Cancer prevention clinical trials. J Clin Oncol 20 18S (2002) 14-22
2. Althuiis M.D., Fergenbaum J.H., Garcia-Closas M., Brinton L.A., Madigan M.P., and Sherman M.E. Etiology of hormone receptor-defined breast cancer: a systematic review of the literature. Cancer Epidemiol Biomarkers Prev 13 10 (2004) 1558-1568
3. Cotterchio M., Kreiger N., Theis B., Sloan M., and Bahl S. Hormonal factors and the risk of breast cancer according to estrogen- and progesterone-receptor subgroup. Cancer Epidemiol Biomarkers Prev 12 (2003) 1053-1060
4. Potter J.D., Cerhan J.R., Sellers T.A., et al. Progesterone and estrogen receptors and mammary neoplasia in the Iowa Women's Health Study: how many kinds of breast cancer are there?. Cancer Epidemiol Biomarkers Prev 4 (1995) 319-326
5. Enger S.M., Ross R.K., Paganini-Hill A., Carpenter C.L., and Bernstein L. Body size, physical activity, and breast cancer hormone receptor status: results from two case-control studies. Cancer Epidemiol Biomarkers Prev 9 (2000) 681-687
6. Huang Z., Willet W.C., Colditz G.A., et al. Waist circumference, waist:hip ratio, and risk of breast cancer in the Nurses' Health Study. Am J Epidemiol 150 (1999) 1316-1324
7. Manger J., Malina J., and Berglund G. Smoking associated with hormone receptor negative breast cancer. Int J Cancer 91 (2001) 580-584
8. Yoo K., Tajima K., Park S., et al. Postmenopausal obesity as a breast cancer risk factor according to estrogen and progesterone receptor status (Japan). Cancer Lett 167 (2001) 57-63
9. De-Waard F., Poortman J., and Collette B.J.A. Relationship of weight to the promotion of breast cancer after menopause. Nutr Cancer 2 (1981) 237-240
10. Papatestas A.E., Panveliwalla D., Pertsem-Lidis D., Mulvihill M., and Alfser A.H. Association between estrogen receptors and weight in women with breast cancer. J Surg Oncol 13 (1980) 177-180
11. Key T.J., Allen N.E., Verkasalo P.K., and Banks E. Macronutrient metabolism group symposium on energy flux and cancer, energy balance and cancer: the role of sex hormones. Proc Nutr Soc 60 (2001) 81-89
12. Folkerd E.J., Martin L.A., Kendall A., and Dowsett M. The relationship between factors affecting endogenous oestradiol levels in postmenopausal women and breast cancer. J Steroid Biochem Mol Biol 102 (2006) 250-255
13. Kreiger N., King W.D., Rosenberg L., Clarke E.A., Palmer J.R., and Shapiro S. Steroid receptor status and the epidemiology of breast cancer. Ann Epidemiol 1 (1991) 513-523
14. Giufrida D., Lupo L., La Porta G.A., et al. Relation between steroid receptor status and body weight in breast cancer patients. Eur J Cancer 28 1 (1992) 112-115
15. Jain M., and Miller A.B. Tumor characteristics and survival of breast cancer patients in relation to premorbid diet and body size. Breast Cancer Res Treat 42 (1997) 43-55
16. Macinnis R.J., English D.R., Gertig D.M., Hopper J.L., and Giles G.G. Body size and composition and risk of postmenopausal breast cancer. Cancer Epidemiol Biomarkers Prev 13 12 (2004) 2117-2125
17. Sellers T.A., Davis J., Cerhan J.R., et al. Interaction of waist/hip ratio and family history on the risk of hormone receptor-defined breast cancer in a prospective study of postmenopausal women. Am J Epidemiol 155 3 (2002) 225-233
18. Li C.I., Malone K.E., and Daling J.R. Interactions between body mass index and hormone therapy and postmenopausal breast cancer risk (United States). Cancer Causes Control 17 (2006) 695-703
19. Suzuky R., Rylander-Rudqvist T., Ye W., Shigehira S., and Wolk A. Body weight and postmenopausal breast cancer risk defined by estrogen and progesterone receptor status among Swedish women: a prospective cohort study. Int J Cancer 119 (2006) 1683-1689
20. Terry M.B., Zhang F.F., Kabat G., et al. Lifetime alcohol intake and breast cancer risk. Ann Epidemiol 16 3 (2006) 230-240
21. Iwasaki M., Otan T., Inoue M., Sasazuki S., and Tsugane S. Body size and risk for breast cancer in relation to estrogen and progesterone receptor status in Japan. Ann Epidemiol 17 4 (2007) 304-312
22. Slattery M.L., Sweeney C., Edwards S., et al. Body size, weight change, fat distribution and breast cancer risk in Hispanic and non-Hispanic white women. Breast Cancer Res Treat 102 (2007) 85-101
23. Huang W.Y., Newman B., Millikan R.C., Schell M.J., Hulka B.S., and Moorman P.G. Hormone-related factors and risk of breast cancer in relation to estrogen receptor and progesterone receptor status. Am J Epidemiol 151 (2000) 703-714
24. Seidell J.C., Cigolini M., Deurenberg P., Oosterlee A., and Doornbos G. Fat distribution, androgens, and metabolism in nonobese women. Am J Clin Nutr 50 (1989) 269-273
25. Olson J.E., Anderson K.E., and Cerhan J.R. An investigation of the biological basis of an interaction of abdominal fat distribution and family history of breast cancer. A nested study of sisters in the Iowa Women's Health Study (United States). Cancer Causes Control 11 (2000) 941-954
26. Kopelman P. Obesity as a medical problem. Nature 404 (2000) 635-643
27. World Health Organization. Obesity: preventing and managing the global epidemic. Report of a WHO consultation on obesity, Geneva, 3-5 June 1997.
28. Britton J.A., Gammon M.D., Schoenberg J.B., et al. Risk of breast cancer classified by joint estrogen receptor and progesterone receptor status among women 20-40 years of age. Am J Epidemiol 156 6 (2002) 507-516
29. Yasui Y., and Potter J.D. The shape of age-incidence curves of female breast cancer by hormone-receptor status. Cancer Causes Control 10 (1999) 431-437
30. Colditz G.A., Rosner B.A., Chen W.Y., Holmes M.D., and Hankinson S.E. Risk factors for breast cancer according to estrogen and progesterone receptor status. J Natl Cancer Inst 96 (2004) 218-228
31. Horwitz K.B. The central role of progesterone receptors and progestational agents in the management and treatment of breast cancer. Semin Oncol 15 2 Suppl. 1 (1988) 14-19
32. Donegan W.L. Prognostic factors. Stage and receptor status in breast cancer. Cancer 70 Suppl. 6 (1992) 1755-1764
33. Kaye S.A., Folson A.R., Soler J.T., Prineas R.J., and Potter J.D. Associations of body mass and fat distribution with sex hormone concentrations in post-menopausal women. Int J Epidemiol 20 (1991) 151-156
34. Bruning P.F., Bonfrer J.M., van Noord P.A., Hart A.A., de Jong-Bakker M., and Nooijen W.J. Insulin resistance and breast cancer risk. Int J Cancer 52 (1992) 511-516